Matrix Asset Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Hold
311
0.03% 84
2026
Q1
$286K Sell
311
-14
-4% -$14.2K 0.03% 93
2025
Q4
$350K Sell
325
-3
-0.9% -$2.87K 0.03% 85
2025
Q3
$251K Buy
328
+3
+0.9% +$2.23K 0.02% 99
2025
Q2
$254K Sell
325
-15
-4% -$11.7K 0.03% 96
2025
Q1
$281K Buy
340
+38
+13% +$31.6K 0.03% 83
2024
Q4
$233K Hold
302
0.03% 103
2024
Q3
$268K Buy
302
+5
+2% +$4.5K 0.03% 90
2024
Q2
$269K Hold
297
0.03% 81
2024
Q1
$231K Buy
+297
New +$211K 0.03% 92

Other funds holding LLY

Matrix Asset Advisors's LLY Position: Q2 2026 in Review

Matrix Asset Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 311 shares worth $372K. The position accounts for 0.03% of the portfolio, ranked #84.

Matrix Asset Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Matrix Asset Advisors held 311 shares of Eli Lilly worth $372K as of Q2 2026.
  • Matrix Asset Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.03% of Matrix Asset Advisors's portfolio in Q2 2026, its #84 holding.
  • Matrix Asset Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Matrix Asset Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.